Visium Asset Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Visium Asset Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-151,200	Closed	-$1M	–	1228
2014 Q1	$1M	Buy	+151,200	New	+$1.05M	0.02%	473
2013 Q3	–	Sell	-105,997	Closed	-$1.5M	–	893
2013 Q2	$1.5M	Buy	+105,997	New	+$1.37M	0.04%	269

Other funds holding CCXI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Visium Asset Management's CCXI Position: Q2 2014 in Review

Visium Asset Management sold out of ChemoCentryx, Inc. (CCXI) in Q2 2014, closing a stake of 151,200 shares — an estimated $1M sold.

Visium Asset Management first reported a position in CCXI in Q2 2013 and held it in 2 quarters. The position peaked at $1.5M in Q2 2013. 66 funds tracked by Wall St. Rank hold CCXI as of Q2 2014.

Visium Asset Management reported no remaining ChemoCentryx, Inc. position as of Q2 2014 after selling out during the quarter.
Visium Asset Management sold 151,200 ChemoCentryx, Inc. shares in Q2 2014, an estimated $1M.
Visium Asset Management first reported a position in ChemoCentryx, Inc. in Q2 2013 and held it in 2 quarters.
Visium Asset Management's ChemoCentryx, Inc. position peaked at $1.5M in Q2 2013.
66 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2014.

Based on Visium Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.